Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Pharmaceuticals Other
|VRX||Valeant Pharmaceuticals International, Inc.||3.27%||29.07||14.1%||$171.05m|
|JAZZ||Jazz Pharmaceuticals Plc||0.57%||179.17||2.2%||$142.15m|
|HZNP||Horizon Therapeutics Plc||5.02%||92.14||5.5%||$124.53m|
|BHC||Bausch Health Cos., Inc.||3.27%||29.07||0.0%||$91.68m|
|SAVA||Cassava Sciences, Inc.||8.31%||40.92||0.0%||$55.78m|
|UTHR||United Therapeutics Corp.||2.12%||197.87||14.0%||$55.65m|
|PRGO||Perrigo Co. Plc||1.80%||45.82||6.9%||$49.71m|
|SAGE||SAGE Therapeutics, Inc.||2.03%||70.86||7.6%||$33.60m|
|PCRX||Pacira Biosciences, Inc.||1.22%||62.21||9.9%||$30.64m|
|AXSM||Axsome Therapeutics, Inc.||-2.68%||58.42||1.9%||$26.79m|
|RVMD||Revolution Medicines, Inc.||4.07%||31.99||0.0%||$23.38m|
Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on June 22, 2005 and is headquartered in Durham, NC.